Evidence map›Paper›PMID 35626006›Full record

ReviewCancers2022

Current Trend of Artificial Intelligence Patents in Digital Pathology: A Systematic Evaluation of the Patent Landscape.

Muhammad Joan Ailia, Nishant Thakur, Jamshid Abdul-Ghafar, Chan Kwon Jung, Kwangil Yim, Yosep Chong

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Biomimicry Industry and Patent Trends.Biomimetics (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad Joan AiliaDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0002-5846-6087
Nishant ThakurDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0001-8761-0837
Jamshid Abdul-GhafarDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0002-6575-8870
Chan Kwon JungDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0001-6843-3708
Kwangil YimDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0001-8767-9033
Yosep ChongDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0001-8615-3064

Funding

Korea Health Industry Development Institute HI21C0940
6 · The paper itself

Abstract

The integration of digital pathology (DP) with artificial intelligence (AI) enables faster, more accurate, and thorough diagnoses, leading to more precise personalized treatment. As technology is advancing rapidly, it is critical to understand the current state of AI applications in DP. Therefore, a patent analysis of AI in DP is required to assess the application and publication trends, major assignees, and leaders in the field. We searched five major patent databases, namely, those of the USPTO, EPO, KIPO, JPO, and CNIPA, from 1974 to 2021, using keywords such as DP, AI, machine learning, and deep learning. We discovered 6284 patents, 523 of which were used for trend analyses on time series, international distribution, top assignees; word cloud analysis; and subject category analyses. Patent filing and publication have increased exponentially over the past five years. The United States has published the most patents, followed by China and South Korea (248, 117, and 48, respectively). The top assignees were Paige.AI, Inc. (New York City, NY, USA) and Siemens, Inc. (Munich, Germany) The primary areas were whole-slide imaging, segmentation, classification, and detection. Based on these findings, we expect a surge in DP and AI patent applications focusing on the digitalization of pathological images and AI technologies that support the vital role of pathologists.

Indexed as

artificial intelligencedeep learningdigital pathologyintellectual propertypatents

Identifiers

PMID35626006
PMCPMC9139645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.